If you or someone you know is affected by the issues raised in Panorama: A Risk Worth Taking?, there is help available. The organisations below have information on diabetes and the drug Avandia.
Diabetes UK works for people with diabetes funding research, campaigning and helping people live with the condition.
Diabetes UK's Careline provides support and information to people with diabetes as well as friends, family and carers. Phone: 0845 120 2960
The Insulin Dependent Diabetes Trust (IDDT)
The trust is a charity concerned with listening to and understanding the needs of people who live with diabetes as well as their carers.
The Juvenile Diabetes Research Foundation
The organisation works to try and find the cure for type one diabetes and its complications.
If you or a loved one have been affected by type one diabetes, find out more by contacting them. Phone: 0207 713 2030
The European Medicines Agency (EMA)
The EMA is a decentralised body of the European Union, which is located in London. Its main responsibility as the European regulator is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.
More information on Avandia, including the ongoing review, is available in the European Public Assessment Report (EPAR) which can be found on the EMA website. The results of the review will be published on the EMA website, once finalised.
Information about the regulation of medicines is also available on the EMA website. Any further queries can be sent directly to the agency using the links below.
The Medicines and Healthcare products Regulatory Agency (MHRA) They are the government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe. The MHRA is an executive agency of the Department of Health.
Avandia is manufactured by GlaxoSmithKline.
The link below provides product-related information for members of the public who have been prescribed a GSK product. Patients taking Avandia who have questions about their treatment should speak with their doctor. Patients are advised not to stop their medication without consulting their doctor.